Research shows that a gene called FTO protects against heart disease by reducing a harmful protein called PRTN3, which normally triggers immune cells to attack blood vessels. In a 2026 study, boosting FTO levels in mice reduced atherosclerosis development and decreased inflammation in arteries. According to Gram Research analysis, this discovery reveals a new genetic pathway that could lead to future heart disease treatments, though human trials are still years away.
Scientists have discovered how a gene called FTO helps protect against heart disease by controlling inflammation in the body. According to Gram Research analysis, FTO works by turning down a protein that causes immune cells to attack blood vessels. In studies with mice, boosting FTO levels reduced atherosclerosis, the dangerous buildup of plaque in arteries. This finding opens a new door for treating heart disease by targeting this specific genetic pathway, potentially offering patients a new way to prevent or slow the disease.
Key Statistics
A 2026 research article found that PRTN3 protein is significantly elevated in blood cells from people with coronary artery disease compared to healthy individuals, suggesting a key role in heart disease development.
In laboratory studies, increasing FTO expression reduced PRTN3 levels and enhanced the survival and growth of blood vessel cells, indicating FTO’s protective effect against atherosclerosis.
Mouse studies showed that boosting FTO via gene therapy reduced atherosclerotic plaque development and decreased neutrophil activation, demonstrating the pathway’s importance in preventing heart disease progression.
The Quick Take
- What they studied: How a gene called FTO protects against atherosclerosis, the buildup of plaque in arteries that causes heart disease
- Who participated: Blood samples from people with heart disease and healthy people, plus lab studies using human cells and mice genetically modified to develop atherosclerosis
- Key finding: FTO reduces a harmful protein called PRTN3, which stops immune cells from attacking blood vessel walls and causing inflammation that leads to heart disease
- What it means for you: This research suggests that boosting FTO activity might prevent or slow heart disease, though human treatments are still years away. People with heart disease risk factors should continue following proven prevention strategies like exercise and healthy eating while scientists develop new therapies.
The Research Details
Researchers compared blood cells from people with heart disease to healthy people, looking for differences in gene activity. They used advanced genetic sequencing to identify which genes were turned up or down in heart disease patients. Then they tested their findings in lab-grown human cells and in mice that were genetically designed to develop atherosclerosis. The team used several techniques to prove that FTO directly controls PRTN3, including special tests that show how genes bind to proteins and how chemical tags on genes affect protein production. Finally, they injected a modified virus carrying extra FTO genes into mice to see if boosting FTO levels would protect against heart disease development.
This research approach is important because it combines human data with lab experiments and animal testing, making the findings more reliable. By studying both what happens in real patients and what happens in controlled lab settings, scientists can better understand whether a discovery will actually work in people. The use of mice with atherosclerosis lets researchers test whether boosting FTO actually prevents heart disease before trying it in humans.
This study used multiple research methods to confirm findings, which strengthens confidence in the results. The researchers tested their theory in human cells, animal models, and used several different lab techniques to verify the same conclusion. However, the study was published in 2026 and involved animal models rather than human trials, so results may not directly translate to treating people yet. The specific sample size of human participants was not clearly stated in the abstract.
What the Results Show
The research shows that PRTN3 protein is significantly higher in people with heart disease compared to healthy people. When FTO was increased in lab cells, it reduced PRTN3 levels and made blood vessel cells grow better and survive longer. In mice, boosting FTO protected against atherosclerosis development, meaning less plaque buildup in their arteries. The protective effect worked because FTO removes chemical tags from PRTN3 genes, which stops the body from making as much of this harmful protein. This reduced PRTN3 then calmed down immune cells called neutrophils, which normally attack blood vessels and cause inflammation.
The study found that PRTN3 activates a communication system between immune cells called the CXCL9/CXCR3 pathway. When this pathway is active, it causes neutrophils to move toward blood vessels and produce harmful molecules called reactive oxygen species that damage vessel walls. By reducing PRTN3, FTO essentially turns down this inflammatory alarm system. The research also showed that when FTO was reduced or removed, the opposite happened: more PRTN3 was made, more immune cells were activated, and blood vessel cells died more easily.
Previous research has shown that FTO affects body weight and metabolism, but this study reveals a completely new role for FTO in protecting blood vessels. Earlier work identified that inflammation and immune system overactivity contribute to heart disease, but this is the first study to show how FTO specifically controls this process through PRTN3. The discovery adds to growing evidence that epigenetic mechanisms, which are chemical switches that turn genes on and off, play a major role in heart disease development.
This study was conducted in laboratory cells and mice, not in people, so results may not work the same way in humans. The exact sample size of human blood donors was not specified, making it unclear how many people were studied. The research focused on one specific pathway, so there may be other ways FTO protects the heart that were not examined. Finally, the study was published very recently, so other scientists have not yet had time to confirm these findings independently.
The Bottom Line
This research is promising but preliminary. People should not expect new heart disease treatments based on FTO for several years. Current proven prevention strategies remain most important: maintain a healthy weight, exercise regularly, eat a heart-healthy diet low in saturated fat, manage stress, and follow your doctor’s advice. If you have heart disease risk factors, discuss screening and prevention with your healthcare provider. Confidence level: This finding is interesting but requires human studies before clinical use.
People with family history of heart disease, those with high cholesterol or high blood pressure, and anyone concerned about atherosclerosis should follow this research. Healthcare providers treating heart disease patients should stay informed about new therapeutic targets. People without heart disease risk factors can benefit from knowing that genetic research is advancing prevention options. This research is not yet ready for people to act on individually.
If FTO-based treatments are developed, they would likely take 5 to 10 years to move from animal studies to human trials. Even then, they would probably be used alongside current treatments, not replace them. Benefits would likely appear gradually over months to years of treatment, similar to how current heart disease medications work.
Frequently Asked Questions
Can FTO gene therapy treat heart disease in people right now?
No, this research is still in early stages using mice and lab cells. Human clinical trials would need to happen first, which typically takes 5 to 10 years. Current proven treatments like medication and lifestyle changes remain the best options for heart disease prevention and management.
Does having a naturally high FTO gene protect you from heart disease?
This study shows FTO can protect against atherosclerosis in mice, but it’s unclear whether natural FTO levels in people determine heart disease risk. Genetics is just one factor; lifestyle, diet, exercise, and other genes also significantly influence heart disease risk.
What is PRTN3 and why does lowering it help prevent heart disease?
PRTN3 is a protein that activates immune cells to attack blood vessel walls, causing inflammation and plaque buildup. By reducing PRTN3, FTO calms this inflammatory response, protecting arteries from damage and atherosclerosis development.
Should I get tested for FTO levels if I have heart disease risk?
Currently, FTO testing is not a standard part of heart disease screening. Focus on proven risk factors like blood pressure, cholesterol, weight, and family history. Talk to your doctor about appropriate screening based on your individual risk profile.
How does this research change current heart disease prevention advice?
This research doesn’t change current prevention strategies yet. Continue following proven approaches: exercise regularly, eat a healthy diet, maintain a healthy weight, manage stress, and take prescribed medications. This discovery may lead to new treatments in the future.
Want to Apply This Research?
- Track heart disease risk factors weekly: blood pressure readings, exercise minutes, and dietary choices like servings of fruits and vegetables. Monitor any family history updates or new health diagnoses that affect cardiovascular risk.
- Use the app to set and track heart-healthy habits: aim for 150 minutes of moderate exercise weekly, reduce saturated fat intake, increase fiber consumption, and maintain a healthy weight. Set reminders for medication if prescribed, and log any symptoms to discuss with your doctor.
- Create a long-term health dashboard tracking blood pressure trends, cholesterol levels from lab work, weight changes, and exercise consistency. Review monthly to identify patterns and share data with your healthcare provider to optimize heart disease prevention strategies.
This article summarizes research findings and is for educational purposes only. It does not constitute medical advice. The research described involves animal studies and laboratory experiments; results may not directly apply to humans. Do not make changes to heart disease prevention or treatment based on this article without consulting your healthcare provider. Anyone with heart disease risk factors or existing heart disease should work with their doctor to develop an appropriate prevention and treatment plan using currently proven strategies.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.